FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079428 [Registered on: 24/01/2025] Trial Registered Prospectively
Last Modified On: 24/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Compartive Study of Nebulized Ropivacaine and Nebulized Ropivacaine with dexmedetomidine 
Scientific Title of Study   A RANDOMIZED STUDY TO COMPARE THE EFFECT OF NEBULIZED ROPIVACAINE AND NEBULIZED ROPIVACAINE WITH DEXMEDETOMIDINE ON ATTENUATING HEMODYNAMIC RESPONSE TO INTUBATION IN PATIENTS UNDERGOING SURGERY UNDER GENERAL ANAESTHESIA 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ashu Agarwal  
Designation  PG student 
Affiliation  Jhalawar medical college Jhalawar  
Address  Department of Anaesthesia , NH 12 KOTA ROAD JHALAWAR

Jhalawar
RAJASTHAN
326001
India 
Phone  9828746500  
Fax    
Email  Ashu98280@gmail.con  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Pratibha Rathore 
Designation  Proffesor 
Affiliation  Jhalawar Medical College Jhalawar 
Address  298, BARKAT NAGAR TONK PHATAK JAIPUR
Anaesthesia department , 1 floor , room no 110 ,NH 12 kota rd jhalawar 326001
Jaipur
RAJASTHAN
302015
India 
Phone  9414446473  
Fax    
Email  PRATIBHA.RATHORE3@GMAIL.COM  
 
Details of Contact Person
Public Query
 
Name  Dr. Pratibha Rathore 
Designation  Proffesor 
Affiliation  Jhalawar Medical College , Jhalwar 
Address  298, BARKAT NAGAR TONK PHATAK JAIPUR
Anaesthesia department, 1 floor, room no 110, NH 12 kota rd jhalawar 326001
Jaipur
RAJASTHAN
302015
India 
Phone  9414446473  
Fax    
Email  PRATIBHA.RATHORE3@GMAIL.COM  
 
Source of Monetary or Material Support  
Jhalawar medical college , Jhalawar,Rajasthan , India, 326001 
 
Primary Sponsor  
Name  Ashu Agarwal 
Address  47,Chankya Marg,Karni Colony,Vijay BARI Path no 7 , Sikar Road,Jaipur,Rajathan 302023 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ashu Agarwal  Jhalawar Medical College  Department of Aanesthesia ,1 foor,room no 110, NH 52 Kota Road, Jhalawar,326001
Jhalawar
RAJASTHAN 
9828746500

ashu98280@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Jhalawar Medical College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K35||Acute appendicitis, (2) ICD-10 Condition: H661||Chronic tubotympanic suppurative otitis media, (3) ICD-10 Condition: N25||Disorders resulting from impairedrenal tubular function, (4) ICD-10 Condition: G89-G99||Other disorders of the nervous system, (5) ICD-10 Condition: M97||Periprosthetic fracture around internal prosthetic joint,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ropivacaine  Nebulize They Patient With 0.5% Ropivacaine See They Hemodynamic Response they total duration of this study is 1.5 years. 
Comparator Agent  Ropivacaine AND Dexemedetomidine  Nebulize They Patient With Ropivacaine And Dexemedetomidine And See They Hemodynamic Response .They total duration of this study is 1.5 years. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patient giving consent for study
2. Weight 40-70 kg
3. ASA grade 1 & 2
4. Patients undergoing surgery under general anaesthesia
5. All lab investigations within normal range

 
 
ExclusionCriteria 
Details  1. Patient with a history of sore throat or upper respiratory tract infection
2. Hemodynamically unstable patients
3. Emergency patients
4. Patients with a history of allergy to local anesthetics
5. Patents with a history of allergy to dexmedetomidine
6. Patients with a history of cardiac, liver, or renal disorders.
7. Patient with a difficult airway where the anticipated duration of laryngoscopy exceeded 15 seconds.
8. ASA 3 and 4
 
 
Method of Generating Random Sequence   Stratified randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
.To access and compare they hemodynamic changes HR , SBP, DBP,MAP, Spo2 and ETco2 in both the groups  Before Nebulization ,After Nebulization, Before Intubation ,After Intubation, 5 minute after intubation ,at skin closure ,after extubation, 5 minutes after extubation 
 
Secondary Outcome  
Outcome  TimePoints 
1. To compare the cough response at extubation in both the groups.
2. The incidence rate of postoperative sore throat. In both the groups.
 
sore throat at time of extubation, 2 hour, 4 hour,6hour,12 hour,24 hour
cought response at time of extubation  
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   22/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="10" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response (Others) - 

  6. For how long will this data be available start date provided 26-11-2024 and end date provided 01-04-2026?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   THIS STUDY IS TO COMAPRE THEY EFFECT OF NEBULIZED ROPIVACAINE AND NEBULIZED ROPIVACAINE WITH DEXMEDETOMIDINE ON THE HEMODYNAMICE RESPONSE TO INTUBATION IN PATIENTS UNDERGOING SURGERY UNDER GENERAL ANAESTHESIA. PREOPERATIVE VITALS ARE MOINTORED AND BEFORE INTUBATION PATIENTS IS NEBULIZED WITH ONE OF THEY GROPUS AND AFTER NEBULIZATION THEY VITALS ARE MONITORED AND THEY ARE VITALS ARE MOINTORED THROUGH OUT THEY PROCEDURE AT DIFFERENT TIME INTERVAL AND AFTER EXTUBATION PATIENTS IS ACCESED FOR SORE THROAT AND COUGH RESPOSNE . ALL THIS DATA WOULD BE ENTRED IN EXCEL SHEET AND FINAL RESULT WOULD BE CONCULUDED. 
Close